Press Release

BioLineRx's Dr. Geffen will present results from Phase 2b EAGLE trial at Schizophrenia International Research Society (SIRS) Conference , Florence, Italy

April 13, 2010
PDF Version
On Thursday April 15,  Yona Geffen, PhD, from BioLineRX will be presenting "A double-blind placebo control study evaluating the efficacy and safety of BL-1020 , a GABA enhanced antipsychotic for the treatment of schizophrenia" at  the SIRS Conference, "Cognition in Schizophrenia" Session.

Press Releases View all

Upcoming Events View all

There are currently no events to display.